You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
衞光生物(002880.SZ):拟参设珠海盈盛联科生物 以经营美白祛疤、抗衰祛皱、修复舒缓等的功能性护肤产品
格隆汇 02-13 18:02

格隆汇2月13日丨衞光生物(002880.SZ)公布,公司第三届董事会第十二次会议决议,审议通过了《关于对外投资设立参股公司的议案》。董事会经审议同意公司与深圳市卓瑞丹景科技管理有限公司(“卓瑞丹景”)、深圳市中凯天聚管理咨询合伙企业(有限合伙)(“中凯天聚”)、深圳市丹粤子耘管理咨询合伙企业(有限合伙)(“丹粤子耘”)合作成立参股公司珠海盈盛联科生物科技有限公司(暂定名,以工商登记为准,“项目公司”)。公司与项目公司其他股东不存在关联关系。

项目公司注册资本拟为1000万元,公司、卓瑞丹景、中凯天聚、丹粤子耘拟占项目公司股权比例分别为10%、50%、30%、10%。

项目公司主要经营美白祛疤、抗衰祛皱、修复舒缓等的功能性护肤产品,包括化粧品原料或者二类医疗器械敷料生产销售。此次合作设立参股公司事项有利于公司充分盘活现有资源,促进公司持续健康发展,符合公司长期发展战略和发展规划。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account